Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA016858-21A1S1
Application #
2086534
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1977-09-01
Project End
1999-04-30
Budget Start
1994-07-01
Budget End
1995-04-30
Support Year
21
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Choi, Sung Hee; Kim, Byung-Gyu; Robinson, Janet et al. (2014) Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. J Clin Invest 124:2472-82
Montano, Ramon F; Penichet, Manuel L; Blackall, Douglas P et al. (2009) Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents. J Immunol Methods 340:1-10
Gala, Francoise A; Morrison, Sherie L (2004) V region carbohydrate and antibody expression. J Immunol 172:5489-94
Gala, Francoise A; Morrison, Sherie L (2002) The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. J Biol Chem 277:29005-11
Helguera, G; Morrison, S L; Penichet, M L (2002) Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy. Clin Immunol 105:233-46
Montano, Ramon F; Morrison, Sherie L (2002) Influence of the isotype of the light chain on the properties of IgG. J Immunol 168:224-31
Penichet, M L; Morrison, S L (2001) Antibody-cytokine fusion proteins for the therapy of cancer. J Immunol Methods 248:91-101
Trinh, K R; Morrison, S L (2000) Site-specific and directional gene replacement mediated by Cre recombinase. J Immunol Methods 244:185-93
Chan, L A; Lyczak, J B; Zhang, K et al. (2000) The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex. Mol Immunol 37:241-52
Mateo, C; Lombardero, J; Moreno, E et al. (2000) Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity. Hybridoma 19:463-71

Showing the most recent 10 out of 100 publications